Your browser doesn't support javascript.
loading
Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.
Veldman, Mark W; Reading, Carl C; Farrell, Michael A; Mullan, Brian P; Wermers, Robert A; Grant, Clive S; Thompson, Geoff B.
Afiliación
  • Veldman MW; Department of Radiology, Mayo Clinic, 200 1st St., SW, Rochester, MN 55902, USA.
AJR Am J Roentgenol ; 191(6): 1740-4, 2008 Dec.
Article en En | MEDLINE | ID: mdl-19020245
ABSTRACT

OBJECTIVE:

The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy.

CONCLUSION:

Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de las Paratiroides / Neoplasia Endocrina Múltiple Tipo 1 / Etanol / Hiperparatiroidismo / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: AJR Am J Roentgenol Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de las Paratiroides / Neoplasia Endocrina Múltiple Tipo 1 / Etanol / Hiperparatiroidismo / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: AJR Am J Roentgenol Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos